Principia Biopharma, A Sanofi Company

This Phase 3 trial tested whether an oral medication called rilzabrutinib could safely and effectively raise and maintain platelet counts in adults and adolescents with persistent or chronic immune thrombocytopenia (ITP). Participants were randomly assigned to receive either the …